NCT03233087 Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study
| NCT ID | NCT03233087 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Institute of Heart, Lung and Blood Vessel Diseases |
| Condition | Aortic Aneurysm |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2014-03-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2014-03-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.
Eligibility Criteria
Inclusion Criteria: Retrospective * All patients who were referred to the surgical service for evaluation and management of aortic dissection were included. Perspective * Patients with initial suspicion of having AAD were perspectively enrolled. Exclusion Criteria: Retrospective * Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken; * Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer; * Patients who entered the hospital for checkups after surgery. Perspective * Patients in whom there is little or no suspicion of a life-threatening disease; * Patients with confirmed acute myocardial infarction,angina or pulmonary embolism * The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03233087 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Aortic Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03233087 currently recruiting?
Yes, NCT03233087 is actively recruiting participants. Contact the research team at wangyuan980510@163.com for enrollment information.
Where is the NCT03233087 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT03233087 clinical trial?
NCT03233087 is sponsored by Beijing Institute of Heart, Lung and Blood Vessel Diseases. The trial plans to enroll 1,500 participants.